# The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves - PII B

Study · id `cardio:ct-nct02184442` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02184442](<https://clinicaltrials.gov/study/NCT02184442>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02184442

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 560 participants.

## Technical summary

Registry record NCT02184442. Randomized; no masking; primary purpose treatment. Start 2011-03-09 (actual); primary completion 2013-05-01 (actual). Results posted on 2018-08-14.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 560 participants (enrolled count; ClinicalTrials.gov record NCT02184442, source copy `cardio:ctgov-nct02184442-2018-09-25`, retrieved 2026-10-26)
- Started: 2011-03-09 (actual) (ClinicalTrials.gov record NCT02184442, source copy `cardio:ctgov-nct02184442-2018-09-25`, retrieved 2026-10-26)
- Primary completion: 2013-05-01 (actual) (ClinicalTrials.gov record NCT02184442, source copy `cardio:ctgov-nct02184442-2018-09-25`, retrieved 2026-10-26)
- Completion: 2017-05-30 (actual) (ClinicalTrials.gov record NCT02184442, source copy `cardio:ctgov-nct02184442-2018-09-25`, retrieved 2026-10-26)
- Results first posted: 2018-08-14 (ClinicalTrials.gov record NCT02184442, source copy `cardio:ctgov-nct02184442-2018-09-25`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT02184442, source copy `cardio:ctgov-nct02184442-2018-09-25`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02184442-2018-09-25`, retrieved 2026-10-26)

## The registry's words

- Brief title: The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves - PII B
- Acronym: PARTNERII B
- Condition: Severe
- Condition: Symptomatic
- Condition: Calcific Aortic Stenosis
- Intervention (Device): TAVR Implantation with SAPIEN XT
- Intervention (Device): TAVR Implantation with SAPIEN
- Lead sponsor: Edwards Lifesciences
- Lead sponsor class: INDUSTRY
- Collaborator: American College of Cardiology
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Edwards Lifesciences (`cardio:edwards-lifesciences`)
- Registry lists this organization as a collaborator: American College of Cardiology (`core:acc`)

## Provenance

Content hash: aeec2654026983505ae6996e498f3d7a6411fa3193f0129cee03a5ca9bca84c6
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
